NO167385C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzazecinderivater. - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzazecinderivater.Info
- Publication number
- NO167385C NO167385C NO870280A NO870280A NO167385C NO 167385 C NO167385 C NO 167385C NO 870280 A NO870280 A NO 870280A NO 870280 A NO870280 A NO 870280A NO 167385 C NO167385 C NO 167385C
- Authority
- NO
- Norway
- Prior art keywords
- chloro
- preparation
- benzazecine
- therapeutic active
- cpds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D227/00—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
- C07D227/02—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D227/06—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D227/08—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH26686 | 1986-01-23 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO870280D0 NO870280D0 (no) | 1987-01-22 |
| NO870280L NO870280L (no) | 1987-07-24 |
| NO167385B NO167385B (no) | 1991-07-22 |
| NO167385C true NO167385C (no) | 1991-10-30 |
Family
ID=4183090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO870280A NO167385C (no) | 1986-01-23 | 1987-01-22 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzazecinderivater. |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US4732979A (is) |
| EP (1) | EP0230967B1 (is) |
| JP (1) | JPS62169770A (is) |
| KR (1) | KR910000659B1 (is) |
| CN (1) | CN1013111B (is) |
| AT (1) | ATE68790T1 (is) |
| AU (1) | AU590042B2 (is) |
| CS (1) | CS258147B2 (is) |
| DD (1) | DD264431A5 (is) |
| DE (1) | DE3773950D1 (is) |
| DK (1) | DK35887A (is) |
| FI (1) | FI82931C (is) |
| GB (1) | GB2185744B (is) |
| HU (1) | HU197883B (is) |
| IE (1) | IE870167L (is) |
| IL (1) | IL81317A (is) |
| IS (1) | IS3190A7 (is) |
| MC (1) | MC1795A1 (is) |
| MT (1) | MTP996B (is) |
| MW (1) | MW187A1 (is) |
| NO (1) | NO167385C (is) |
| NZ (1) | NZ218987A (is) |
| OA (1) | OA08469A (is) |
| PH (1) | PH22879A (is) |
| PL (1) | PL263796A1 (is) |
| PT (1) | PT84181B (is) |
| TN (1) | TNSN87006A1 (is) |
| YU (1) | YU7087A (is) |
| ZA (1) | ZA87407B (is) |
| ZW (1) | ZW1087A1 (is) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3773950D1 (de) * | 1986-01-23 | 1991-11-28 | Hoffmann La Roche | Benzazecin-derivate. |
| IN167395B (is) * | 1987-07-21 | 1990-10-20 | Hoffmann La Roche | |
| US5250539A (en) * | 1991-08-21 | 1993-10-05 | Eli Lilly And Company | Hexahydrobenzo[f]quinolinones |
| ES2169026T3 (es) * | 1991-08-21 | 2002-07-01 | Lilly Co Eli | Benzo(f)quinolinonas como inhibidores de 5-alfa-reductasa. |
| US5239075A (en) * | 1991-08-21 | 1993-08-24 | Eli Lilly And Company | Process for the preparation of benzo (f) quinolinones |
| ES2125884T3 (es) * | 1991-08-21 | 1999-03-16 | Lilly Co Eli | Hexahidrobenzo(f)quinolinonas como inhibidores de la 5-alfa-reductasa. |
| WO1994022444A1 (en) * | 1993-03-29 | 1994-10-13 | Smithkline Beecham Corporation | Tricyclic compounds for inhibiting platelet aggregation |
| GB9317314D0 (en) * | 1993-08-20 | 1993-10-06 | Smithkline Beecham Corp | Compounds |
| JPH10508579A (ja) | 1994-09-20 | 1998-08-25 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | シナプス伝達を改善する薬 |
| US20050067341A1 (en) * | 2003-09-25 | 2005-03-31 | Green Dennis H. | Continuous production membrane water treatment plant and method for operating same |
| US7094331B2 (en) * | 2003-11-05 | 2006-08-22 | Marathon Ashland Petroleum Llc | Viscosity modification of heavy hydrocarbons using dihydric alcohols |
| US20090263439A1 (en) * | 2008-04-18 | 2009-10-22 | The Procter & Gamble Company | Antimicrobial Preservative Free Wipe |
| CN106117028B (zh) * | 2016-06-14 | 2019-01-01 | 浙江永太药业有限公司 | 一种制备卤代-3,4-二氢-1h-2-萘酮的工艺方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE442586A (is) * | 1940-07-31 | |||
| JPS5129710B2 (is) * | 1972-09-09 | 1976-08-27 | ||
| US4341786A (en) * | 1981-03-02 | 1982-07-27 | Smithkline Corporation | Pharmaceutical compositions and method of producing central alpha1 agonist activity utilizing octahydrobenzo[f]quinoline compounds |
| US4521423A (en) * | 1983-10-31 | 1985-06-04 | Ayerst, Mckenna & Harrison, Ltd. | 7,8,9,10-Tetrahydrobenzo[h]quinolin-9-amine derivatives and compositions and methods for treating depression employing them |
| DE3773950D1 (de) * | 1986-01-23 | 1991-11-28 | Hoffmann La Roche | Benzazecin-derivate. |
-
1987
- 1987-01-20 DE DE8787100733T patent/DE3773950D1/de not_active Expired - Lifetime
- 1987-01-20 FI FI870220A patent/FI82931C/fi not_active IP Right Cessation
- 1987-01-20 NZ NZ218987A patent/NZ218987A/en unknown
- 1987-01-20 PH PH34744A patent/PH22879A/en unknown
- 1987-01-20 ZA ZA87407A patent/ZA87407B/xx unknown
- 1987-01-20 MW MW1/87A patent/MW187A1/xx unknown
- 1987-01-20 EP EP87100733A patent/EP0230967B1/de not_active Expired - Lifetime
- 1987-01-20 YU YU00070/87A patent/YU7087A/xx unknown
- 1987-01-20 AT AT87100733T patent/ATE68790T1/de not_active IP Right Cessation
- 1987-01-20 IL IL81317A patent/IL81317A/xx unknown
- 1987-01-20 CS CS87418A patent/CS258147B2/cs unknown
- 1987-01-21 DD DD87299380A patent/DD264431A5/de unknown
- 1987-01-21 ZW ZW10/87A patent/ZW1087A1/xx unknown
- 1987-01-21 HU HU87163A patent/HU197883B/hu not_active IP Right Cessation
- 1987-01-21 US US07/005,712 patent/US4732979A/en not_active Expired - Fee Related
- 1987-01-22 TN TNTNSN87006A patent/TNSN87006A1/fr unknown
- 1987-01-22 GB GB8701416A patent/GB2185744B/en not_active Expired
- 1987-01-22 IS IS3190A patent/IS3190A7/is unknown
- 1987-01-22 MT MT996A patent/MTP996B/xx unknown
- 1987-01-22 AU AU67911/87A patent/AU590042B2/en not_active Ceased
- 1987-01-22 NO NO870280A patent/NO167385C/no unknown
- 1987-01-22 IE IE870167A patent/IE870167L/xx unknown
- 1987-01-22 JP JP62011477A patent/JPS62169770A/ja active Pending
- 1987-01-22 MC MC871868A patent/MC1795A1/xx unknown
- 1987-01-22 CN CN87100312A patent/CN1013111B/zh not_active Expired
- 1987-01-22 DK DK035887A patent/DK35887A/da not_active Application Discontinuation
- 1987-01-22 PT PT84181A patent/PT84181B/pt not_active IP Right Cessation
- 1987-01-23 KR KR1019870000533A patent/KR910000659B1/ko not_active IP Right Cessation
- 1987-01-23 OA OA59052A patent/OA08469A/xx unknown
- 1987-01-23 PL PL1987263796A patent/PL263796A1/xx unknown
- 1987-11-18 US US07/121,987 patent/US4749791A/en not_active Expired - Fee Related
-
1988
- 1988-02-11 US US07/154,760 patent/US4876340A/en not_active Expired - Fee Related
-
1989
- 1989-08-17 US US07/395,380 patent/US4957911A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO167385C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzazecinderivater. | |
| NO832794L (no) | Mellomprodukter for fremstilling av omeprazoler | |
| NO169492C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2',3'-dideoksy-2'-fluornukleosider | |
| LU88790I2 (fr) | Moxidectin et ses dérivés pharmaceutiquement acceptables | |
| ATE82294T1 (de) | Therapeutische nukleoside. | |
| KR900701756A (ko) | 축합된 피라졸 3-옥소-프로판니트릴 유도체 및 이의 제조방법 | |
| GR3005176T3 (is) | ||
| NO174963C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider | |
| FI870974A (fi) | Nya foereningar, vilka aer mellanprodukter vid framstaellning av terapeutiskt anvaendbara ortokondenserade pyrrolderivat. |